Search

everythinglearnresearchcommunity

for

Search:↓

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

The GH-IGF-I axis is likely involved in the hormonal imbalances seen in non-obese women with functional hyperandrogenism.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

Hyperandrogenism is a common hormonal disorder in women, often linked to PCOS.

Measuring plasma testosterone glucosiduronate is a reliable way to detect high male hormone levels in women.

Most women with too much androgens have PCOS, which can be managed with birth control pills, medication for hair growth, and fertility treatments, and losing weight helps too.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

Venous catheterization may help diagnose the cause of female hyperandrogenism when imaging is unclear.

Women also use 5α-reductase inhibitors for hair loss and hirsutism.

Female hyperandrogenism is a condition caused by too much male hormones, leading to skin issues and ovulation problems, often due to Polycystic Ovary Syndrome, and is treated based on individual symptoms.

Women with high androgen levels may have more severe COVID-19 symptoms.

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

Hair loss in women can be caused by genetics, menopause, certain health conditions, and emotional stress, and it often results in thinner hair and a changing hairline.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

The document concludes that HAIR-AN syndrome should be considered when a patient shows severe hyperandrogenism and insulin resistance after excluding tumors.

A patient with HAIR-AN syndrome, PCOS, and Hashimoto's thyroiditis improved with early diagnosis and treatment to prevent serious health problems.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

A woman's rare benign tumor that released both cortisol and testosterone was successfully removed, improving her health.

Blood AMH levels are higher in women with PCOS than in those with other similar conditions.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

There are many ways to treat Polycystic Ovary Syndrome, including lifestyle changes, surgery, and various medications, but more research is needed for better treatments.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

The article suggests renaming Polycystic Ovarian Syndrome (PCOS) to "Hyperandrogenic Persistent Ovulatory Dysfunction Syndrome" (HA-PODS) for accuracy and consistency, but no final decision was made.

The article concludes that hormonal therapy is an effective long-term acne treatment, even for those without hormonal imbalances.